Search

Long-lasting symptoms after SARS-CoV-2 infection have been described many times in the literature and are referred to as Long COVID. In this prospective, longitudinal, monocentric, observational study, we collected the health complaints of 474 patients (252 ambulatory and 222 hospitalized) at Lausanne University Hospital 1 year after COVID-19 diagnosis. Using a self-reported health survey, we explored cardiopulmonary, vascular, neurological, and psychological complaints. Our results show that age, Charlson comorbidity index, and smoking habits were associated with hospital admission. Regarding the vascular system, we found that having had thromboembolism before SARS-CoV-2 infection was significantly associated with a higher risk of recurrence of thromboembolism at 1 year. In the neurologic evaluation, the most frequent symptom was fatigue, which was observed in 87.5% of patients, followed by “feeling slowed down”, headache, and smell disturbance in 71.5%, 68.5%, and 60.7% of cases, respectively. Finally, our cohort subjects scored higher overall in the STAI, CESD, Maastricht, and PSQI scores (which measure anxiety, depression, fatigue, and sleep, respectively) than the healthy population. Using cluster analysis, we identified two phenotypes of patients prone to developing Long COVID. At baseline, CCS score, prior chronic disease, stroke, and atrial fibrillation were associated with Long COVID. During COVID infection, mechanical ventilation and five neurological complaints were also associated with Long COVID. In conclusion, this study confirms the wide range of symptoms developed after COVID with the involvement of all the major systems. Early identification of risk factors associated with the development of Long COVID could improve patient follow-up; nevertheless, the low specificity of these factors remains a challenge to building a systematic approach.

Aims Right ventricular systolic dysfunction (RVSD) is an important determinant of outcomes in heart failure (HF) cohorts. While the quantitative assessment of RV function is challenging using 2D-echocardiography, cardiac magnetic resonance (CMR) is the gold standard with its high spatial resolution and precise anatomical definition. We sought to investigate the prognostic value of CMR-derived RV systolic function in a large cohort of HF with reduced ejection fraction (HFrEF). Methods and results Study cohort comprised of patients enrolled in the CarDiac MagnEtic Resonance for Primary Prevention Implantable CardioVerter DefibrillAtor ThErapy registry who had HFrEF and had simultaneous baseline CMR and echocardiography (n = 2449). RVSD was defined as RV ejection fraction (RVEF) Conclusion RV systolic dysfunction is an independent predictor of ACM in HFrEF, with a more pronounced prognostic value in select subgroups, likely reflecting the importance of RVSD in the early stages of HF progression.

A new magnetic resonance imaging strategy is presented for accessing myocardial perfusion. Most previous work has relied on using T1-weighted fast gradient-echo imaging to monitor dynamically the signal changes during the passage of a contrast media bolus. However, the gradient-echo approach is limited by an inability to image the entire heart with adequate temporal resolution. This paper focuses on a electrocardiogram-gated multishot echo-planar imaging sequence, using the simple strategy of using the intrinsic T1 weighting produced by a repetition time equal to the heart period. To quantitate the sequence's performance with respect to normal myocardial perfusion, seven volunteers were imaged, each with three different doses of the contrast medium gadolinium diethylenetriamine penta-acetic acid (Gd-DTPA). The first-pass dynamics of the contrast were quantified in 13 regions per heart for each examination. In all volunteers, the complete heart could be covered, with five to seven slices, every two heartbeats. Enhancement was homogeneous throughout the left ventricular myocardium, with an enhancement of approximately 50% for the optimum contrast dose of 0.05 mmol/kg Gd-DTPA.

Although the clinical manifestations of Valsalva's maneuver are well known, the associated hemodynamic changes in the great vessels have not been extensively studied and documented. In each of six healthy subjects, we evaluated three “quasi-steady-state” phases of Valsalva's maneuver: (1) during normal respiration, (2) during late strain, and (3) 4 seconds after strain release. Continuous flow, velocity, and cross-sectional area measurements were obtained in the superior vena cava, pulmonary trunk, and thoracic aorta with single-shot echo-planar MR imaging (EPI) with velocity-encoded gradients, which provided 256 Images in 5 seconds, yielding 26 velocity-encoded images per second. In the superior vena cava, Valsalva's maneuver induced an 11% decrease in average flow volume, a 102% increase in peak flow velocity, a 156% increase in the time velocity integral, and a 37% decrease in cross-sectional area. MR velocity measurements agreed with echo-cardiographic data and supplied additional information on flow and morphology. EPI showed a reduction in venous return during Valsalva's maneuver by simultaneously assessing flow, velocity, and vessel morphology; this technique appears to be useful in the analysis of flow dynamics of the great vessels.